Evidence map›Paper›PMID 34807259›Full record

ArticleJAMA network open2021

A Natural Language Processing-Based Approach for Identifying Hospitalizations for Worsening Heart Failure Within an Integrated Health Care Delivery System.

Andrew P Ambrosy, Rishi V Parikh, Sue Hee Sung, Anand Narayanan, Rajeev Masson, Phuong-Quang Lam, Kevin Kheder, Alan Iwahashi, Alexander B Hardwick, Jesse K Fitzpatrick and 6 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Artificial Intelligence in Cardiovascular Clinical Trials.Journal of the American College of Cardiology · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Andrew P AmbrosyDepartment of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
Rishi V ParikhDivision of Research, Kaiser Permanente Northern California, Oakland.
Sue Hee SungDivision of Research, Kaiser Permanente Northern California, Oakland.
Anand NarayananDepartment of Medicine, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
Rajeev MassonDepartment of Medicine, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
Phuong-Quang LamDepartment of Medicine, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
Kevin KhederDepartment of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
Alan IwahashiDepartment of Medicine, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
Alexander B HardwickDepartment of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
Jesse K FitzpatrickDepartment of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
Harshith R AvulaDepartment of Cardiology, Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, California.
Van N SelbyDepartment of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
Xian ShenNovartis Pharmaceuticals Corporation, East Hanover, New Jersey.
Navneet SangheraNovartis Pharmaceuticals Corporation, East Hanover, New Jersey.
Joaquim CristinoDepartment of Cardiology, Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, California.
Alan S GoDivision of Research, Kaiser Permanente Northern California, Oakland.
Kaiser Permanente San Francisco Medical Center · USKaiser Permanente · USKaiser Permanente Walnut Creek Medical Center · USNovartis (United States) · US

Funding

Outpatient Worsening Heart Failure in an Integrated Health Care Delivery System: An Innovative Approach to Characterizing a Novel Clinical EntityK23HL150159 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI AMBROSY, ANDREW PATRICK · 2020 to 2024
$962k
NHLBI NIH HHS K23 HL150159
6 · The paper itself

Abstract

Importance: The current understanding of epidemiological mechanisms and temporal trends in hospitalizations for worsening heart failure (WHF) is based on claims and national reporting databases. However, these data sources are inherently limited by the accuracy and completeness of diagnostic coding and/or voluntary reporting. Objective: To assess the overall burden of and temporal trends in the rate of hospitalizations for WHF. Design, Setting, and Participants: This cohort study, performed from January 1, 2010, to December 31, 2019, used electronic health record (EHR) data from a large integrated health care delivery system. Exposures: Calendar year trends. Main Outcomes and Measures: Hospitalizations for WHF (ie, excluding observation stays) were defined as 1 symptom or more, 2 objective findings or more including 1 sign or more, and 2 doses or more of intravenous loop diuretics and/or new hemodialysis or continuous kidney replacement therapy. Symptoms and signs were identified using natural language processing (NLP) algorithms applied to EHR data. Results: The study population was composed of 118 002 eligible patients experiencing 287 992 unique hospitalizations (mean [SD] age, 75.6 [13.1] years; 147 203 [51.1%] male; 1655 [0.6%] American Indian or Alaska Native, 28 451 [9.9%] Asian or Pacific Islander, 34 903 [12.1%] Black, 23 452 [8.1%] multiracial, 175 840 [61.1%] White, and 23 691 [8.2%] unknown), including 65 357 with a principal discharge diagnosis and 222 635 with a secondary discharge diagnosis of HF. The study population included 59 868 patients (20.8%) with HF with a reduced ejection fraction (HFrEF) (<40%), 33 361 (11.6%) with HF with a midrange EF (HFmrEF) (40%-49%), 142 347 (49.4%) with HF with a preserved EF (HFpEF) (≥50%), and 52 416 (18.2%) with unknown EF. A total of 58 042 admissions (88.8%) with a primary discharge diagnosis of HF and 62 764 admissions (28.2%) with a secondary discharge diagnosis of HF met the prespecified diagnostic criteria for WHF. Overall, hospitalizations for WHF identified on NLP-based algorithms increased from 5.2 to 7.6 per 100 hospitalizations per year during the study period. Subgroup analyses found an increase in hospitalizations for WHF based on NLP from 1.5 to 1.9 per 100 hospitalizations for HFrEF, from 0.6 to 1.0 per 100 hospitalizations for HFmrEF, and from 2.6 to 3.9 per 100 hospitalizations for HFpEF. Conclusions and Relevance: The findings of this cohort study suggest that the burden of hospitalizations for WHF may be more than double that previously estimated using only principal discharge diagnosis. There has been a gradual increase in the rate of hospitalizations for WHF with a more noticeable increase observed for HFpEF.

Indexed as

Disease ProgressionNatural Language ProcessingAgedCohort StudiesDelivery of Health Care, IntegratedFemaleForecastingHeart FailureHospitalizationHumansMaleMiddle AgedPrognosis

Identifiers

PMID34807259
PMCPMC8609413
OpenAlexW3216762281

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.